A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2).
Sehgal IS, Agarwal R, Jindal A, Siddiqui MS, Mohan A, Pal A, Guleria R, Bhalla A, Kajal K, Malhotra P, Puri GD, Khadanga S, Joshi R, Singh S, Saigal S, Nagarkar NM, Suri V, Bhatnagar S, Tiwari P, Singh MP, Yaddanapudi LN, Mittal S, Chauhan A, Banerjee G, Rai DK, Gupta BK; ARMY-2 trial study group*.
Sehgal IS, et al. Among authors: kajal k.
Lung India. 2024 Mar 1;41(2):84-92. doi: 10.4103/lungindia.lungindia_426_23. Epub 2024 Feb 27.
Lung India. 2024.
PMID: 38700400
Free PMC article.